Reversal of multifocal cutaneous lymphoproliferative disease associated with Epstein-Barr virus after withdrawal of methotrexate therapy for rheumatoid arthritis

Journal of the American Academy of Dermatology

Volumn 57, Issue 5 SUPPL., 2007, Pages

  Maruani, Annabel ^a   Wierzbicka, Ewa ^a   Machet, Marie Christine ^a   Abdallah Lotf, Myriam ^a   de Muret, Anne ^a   Machet, Laurent ^a  

^a UNIVERSITÉ DE TOURS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; METHOTREXATE;

AGED; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOPROLIFERATIVE DISEASE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SKIN DEFECT;

EID: 35148830443     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2005.09.015     Document Type: Article

References (14)

1. Nalesnik M.A., Jaffe R., Starzl T.E., Demetris A.J., Porter K., Burnham J.A., et al. Pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 133 (1988) 173-192
2. Loren A.W., Porter D.L., Stadtmauer E.A., and Tsai D.E. Post-transplant lymphoproliferative disorder: a review. Bone Marrow Transplant 31 (2003) 145-155
3. Kamel O.W., Van de Rijn M., Weiss L.M., Del Zoppo G.J., Hench P.K., Robbins B.A., et al. Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med 328 (1993) 1317-1321
4. Tournadre A., d'Incan M., Dubost J.J., Franck F., Dechelotte P., Souteyrand P., et al. Cutaneous lymphoma associated with Epstein-Barr virus infection in 2 patients treated with methotrexate. Mayo Clin Proc 76 (2001) 845-848
5. Kamel O.W., van de Rijn M., LeBrun D.P., Weiss L.M., Warnke R.A., and Dorfman R.F. Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression. Hum Pathol 25 (1994) 638-643
6. Theate I., Michaux L., Dardenne S., Guiot Y., Briere J., Emile F.J., et al. Epstein-Barr virus-associated lymphoproliferative disease occurring in a patient with sarcoidosis treated by methotrexate and methylprednisolone. Eur J Haematol 69 (2002) 248-253
7. Paul C., Le Tourneau A., Cayuela J.M., Devidas A., Robert C., Molinie V., et al. Epstein-Barr virus-associated lymphoproliferative disease during methotrexate therapy for psoriasis. Arch Dermatol 133 (1997) 867-871
8. Blokx W.A., Andriessen M.P., van Hamersvelt H.W., and van Krieken J.H. Initial spontaneous remission of posttransplantation Epstein Barr virus-related B-cell lymphoproliferative disorder of the skin in a renal transplant recipient: case report and review of the literature on cutaneous B-cell posttransplantation lymphoproliferative disease. Am J Dermatopathol 24 (2002) 414-422
9. Zompi S., Tulliez M., Conti F., Leblond V., Gaulard P., Blanche P., et al. Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with clonal lymphoproliferative disorders after orthotopic liver transplantation: a report of three cases. J Hepatol 32 (2000) 521-527
10. Heslop H.E., Savoldo B., and Rooney C.M. Cellular therapy of Epstein-Barr-virus-associated post-transplant lymphoproliferative disease. Best Pract Res Clin Haematol 17 (2004) 401-413
11. Salloum E., Cooper D.L., Howe G., Lacy J., Tallini G., Crouch J., et al. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatoic diseases. J Clin Oncol 14 (1996) 3050-3051
12. Liote F., Pertuiset E., Cochand-Priollet B., D'Agay M.F., Dombret H., Numeric P., et al. Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis. Role of Epstein-Barr virus infection. J Rheumatol 22 (1995) 1174-1178
13. Kamel O.W., Holly E.A., van de Rijn M., Lele C., and Sah A. A population based, case control study of non-Hodgkin's lymphoma in patients with rheumatoid arthritis. J Rheumatol 26 (1999) 1676-1680
14. Feng W.H., Cohen J.I., Fischer S., Li L., Sneller M., Goldbach-Mansky R., et al. Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas. J Natl Cancer Inst 96 (2004) 1691-1702